Literature DB >> 3542125

Naloxone-insensitive potentiation of neurotensin hypothermic effect by the enkephalinase inhibitor thiorphan.

A Coquerel, I Dubuc, J F Menard, P Kitabgi, J Costentin.   

Abstract

The hypothermic effect of neurotensin (0.1 microgram) injected i.c.v. in mice is potentiated by the enkephalinase inhibitor thiorphan (10 micrograms, i.c.v.). This potentiation is not reversed by systemic naloxone. The hypothermic effect of neurotensin is not modified by the amino-peptidase inhibitor bestatin (50 micrograms, i.c.v.) nor by the angiotensin-converting enzyme inhibitor captopril (50 micrograms, i.c.v.). These data indicate the involvement of enkephalinase in the inactivation of neurotensin, at least when it is injected i.c.v.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3542125     DOI: 10.1016/0006-8993(86)91501-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Altered morphine-induced analgesia in neurotensin type 1 receptor null mice.

Authors:  G Roussy; H Beaudry; M Lafrance; K Belleville; N Beaudet; K Wada; L Gendron; P Sarret
Journal:  Neuroscience       Date:  2010-08-18       Impact factor: 3.590

2.  Opposite central and peripheral control by endogenous opioids of intestinal motility in fed rats.

Authors:  P J Rivière; M Liberge; D Murillo-Lopez; L Bueno
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

3.  Purification and properties of a neurotensin-degrading endopeptidase from pig brain.

Authors:  P E Millican; A J Kenny; A J Turner
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.